Wegovy is FDA-approved for promoting weight loss and reducing the risk of cardiovascular problems such as heart attack, stroke, and cardiovascular death in patients with obesity and overweight when paired with lifestyle modifications such as low-calorie diet and exercise
For many patients undergoing a treatment program, improvements can be sustained when the condition is suitable and the recommended activity advice and rehabilitation plan are followed
Researchers can order Dihexa online to include in their collection of research peptides for mechanistic and exploratory studies
Shanmugam N, Reddy MA, Guha M, Natarajan R
Updated Phase 3 data from December 2025 (TRIUMPH-4 trial) pushed those numbers even higher, with the 12mg dose delivering 28.7% weight loss at 68 weeks, which works out to approximately 71 lb lost on average